TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Unisync Corp. (“Unisync”) (TSX: UNI) (OTC: USYNF) today announced that Douglas F. Good, the Company’s Chief Executive Officer, will retire as CEO and a director effective July 15, 2025. Chairman Tim Gu will assume the role of Executive Chairman, providing continuity and oversight as the Company continues to maximize shareholder value. Mr. Good was instrumental in forming Unisync as it exists today, beginning with the acquisition of Peerless Garments in 2010. He led ...

Core Insights - Galapagos NV has appointed Mr. Aaron Cox as Chief Financial Officer, effective July 7, 2025, succeeding Mr. Thad Huston, who will assist in the transition until July 31, 2025 [1][2] Group 1: Leadership Transition - Aaron Cox brings over 20 years of experience in biotechnology, capital markets, and M&A, having previously served as CFO at Horizon Therapeutics, where he was instrumental in the company's $28 billion acquisition by Amgen [2] - Cox's role at Galapagos will involve leading Finance, Accounting, Tax, Procurement, Communications, and Investor Relations, and he will be part of the Executive Committee [3] Group 2: Strategic Goals - The CEO of Galapagos expressed confidence in Cox's ability to accelerate pipeline growth through business development and disciplined financial management, aiming to create a new pipeline of innovative medicines [3] - Cox emphasized his excitement to join Galapagos at a pivotal moment, focusing on creating shareholder value and advancing innovations for patients [4] Group 3: Company Overview - Galapagos is a biotechnology company dedicated to transforming patient outcomes through innovative science, with a focus on high unmet medical needs and a commitment to delivering results for patients and shareholders [6]